Standard for the use of the Chinese classification system for drug-related problems.
10.3760/cma.j.cn112150-20220316-00248
- Collective Name:Clinical Pharmaceutical Administration Committee of Shanghai Hospital Association;Hospital Pharmacy Professional Committee of Shanghai Pharmaceutical Association
- Publication Type:Journal Article
- MeSH:
China;
Humans;
Pharmacists
- From:
Chinese Journal of Preventive Medicine
2022;56(8):1042-1049
- CountryChina
- Language:Chinese
-
Abstract:
The discovery, resolution, intervention and evaluation of drug-related problems (DRPs) are core processes for pharmacists to perform pharmaceutical care. Based on the literature and data of foreign DRPs classification system and current pharmaceutical practice experience, the Chinese DRPs classification system was initially established after selection and integration, and then gradually improved through multiple rounds of public verification method. Finally, a standard for the use of the "Chinese Drug-related Problems Classification System" that conforms to the Chinese population and medical model was formed. The Chinese DRPs classification system includes six parts, i.e., problem, DRP evaluation, cause, intervention plan, acceptance of intervention plan, and DRP status. It aims to provide a basis for Chinese pharmacists to carry out standard and standardized pharmaceutical care and improve the quality of clinical drug treatment management.
